The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...

The FDA has approved a supplemental biologics application for Leqembi Iqlik subcutaneous injection for maintenance dosing in ...

Zepbound is a prescription injectable medication that’s used for weight loss. You or a caregiver can administer it as a subcutaneous injection into your stomach or thigh. A caregiver can also ...

After 18 months of intravenous administration of lecanemab (Leqembi), patients may now transition to subcutaneous delivery using the Leqembi Iqlik autoinjector.

The FDA has approved the BLA for Leqembi Iqlik, a once weekly lecanemab-irmb SC injection, for maintenance dosing to treat Alzheimer disease.

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance ...